ANTIGENBINDENDE PROTEINE ZUR BINDUNG VON IGF1R

Patent europeic · EP2863947 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2863947
Numer da la dumonda
EP13806910
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
12-06-2013
Publitgà
29-04-2015
Concedì
07-03-2018
Stritgà
30-06-2018
Motiv
Taxa annuala betg pajada
Classas IPC
A61K 39/395 (2006.01)
A61P 35/00 (2006.01)
C07K 16/30 (2006.01)
C07K 16/28 (2006.01)
Prioritad
US 201261662905 P 21.06.2012
Dumonda PCT
PCT/US2013/045393 12.06.2013
Publicaziun PCT
WO2013/191982 27.12.2013
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 05-02-2025

    Transferì

    Owner
    Sorrento Therapeutics, Inc., 6042 Cornerstone Court West, San Diego, CA 92121, USA → Vivasor, Inc, 9380 Judicial Drive, San Diego, California 92121, USA

    Published in Swissreg on 05.02.2025

  2. 23-01-2019

    Stritgà, taxa betg pajada

    Published in Swissreg on 23.01.2019

  3. 07-03-2018

    Concedì

    Published in Swissreg on 07.03.2018

Partidas

Inventur

GASTWIRT, Randy

San Diego, CA 92109, US

ZHOU, Heyue

San Diego, CA 92127, US

LU, Guodi

San Diego, CA 92130, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.